Indian drugmaker Koye Pharma has partnered with Sonde Health to develop its vocal biomarker technology – which aims to diagnose diseases from voice patterns – for use in chronic obstructive
Sonde Health has launched a new version of its vocal biomarker technology – which aims to diagnose diseases from a person's voice patterns – that it says can be used to monitor mental healt
Sonde Health has joined forces with chipmaker Qualcomm to develop a technology platform that could diagnose human health conditions from a short sample of speech.
In a new white paper from the World Without Disease initiative, a 2024 update is provided of the current endeavours and developments that have occurred since inaugural discussions last year
